Amgen to Buy Turkish Drugmaker for $700 mln

25.04.2012 - U.S. biotech company Amgen is to buy Turkey's Mustafa Nevzat Pharmaceuticals, a maker of injectable generic drugs, for around $700 million in a deal underscoring Western drugmakers...